Anti-beta2-Glycoprotein I Antibody and Hypertension in Cerebral Ischemia

Clinical and Applied Thrombosis/Hemostasis

Volumn 10, Issue 1, 2004, Pages 55-60

  Chen, Wei Hsi ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Anti beta2 glycoprotein I antibody; Cerebral ischemia; Hypertension

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; SERUM GLOBULIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; FEMALE; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS;

EID: 2142703699     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960401000109     Document Type: Article

References (31)

1. Chen WH, Kao YF, Lan MY, et al. A perturbation of antithrombin III and protein coupling associates with an increase of anti-beta2-glycoprotein I antibody in non-APS cerebral ischemia. Blood Coag Fibrinolysis 2002;13:703.
2. Nagaraja D, Christopher R, Manjari T. Anticardiolipin antibodies in ischemic stroke in the young: Indian experience. J Neurol Sci 1997;150:137.
3. Montalban J, Codina A, Ordi J, et al. Antiphospholipid antibodies dbodies in cerebral ischemia. Stroke 1991;22:750.
4. Chen WH, Liu JS. An unusual increase of blood anti-beta 2-glycoprotein-I antibody but not antiphospholipid antibody in cerebral ischemia. Angiology 2001;52:149.
5. Heinzlef O, Abuaf N, Cohen A, et al. Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: A prospective study. J Neurol 2001;248:373.
6. Granel F, de Maistre E, Challier B, et al. Ischemic stroke in young patients and/or livedo: Is it important to look for anti-beta 2-glycoprotein I antibodies? [Fre]. Rev Med Interne 1998;19:709.
7. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115.
8. Fu ML. Abnormal immune system and hypertension: Where are we? Ann Med 1995;27:671.
9. Chen WH, Lan MY, Chang YY, et al. The prevalence of protein C, protein S and antithrombin III deficiency in non-APS/SLE Chinese adults with noncardiac cerebral sichemia. Clin Appl Thromb/Hemost 2003;9:155.
10. Chen WH, Chang YY, Chou MS, et al. The lipoprotein profile of young adults with cerebral atherosclerosis. Southeast Asian J Trop Med Publ Health 1996;27:178.
11. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752.
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythrematosus. Arthritis Rheum 1982;25:1271.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythrematosus. Arthritis Rheum 1997; 40:1725.
14. Frostegard J, Wu R, Gillis-Haegerstrand C, et al. Antibodies to endothelial cells in borderline hypertension. Circulation 1998;98:1092.
15. Fiallo P, Tomasina C, Clapasson A, et al. Antibodies to beta (2)-glycoprotein I in ischemic stroke. Cerebrovasc Dis 2000;10:293.
16. Valdes-Macho E, Cabiedes J, Villa AR, et al. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy. Arch Med Res 2002;33:460.
17. Sherer Y, Tenenbaum A, Praprotnik S, et al. Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension. Cardiology 2002;97:2.
18. Arnett FC, Thiagarajan P, Ahn C, et al. Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum 1999;42:268.
19. Blann AD, Tse W, Maxwell SJ, Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994;12:925.
20. Felmeden DC, Spencer CG, Belgore FM, et al. Endothelial damage and angiogenesis in hypertensive patients: Relationship to cardiovascular risk factors and risk factor management. Am J Hypertens 2003;16:11.
21. Chen WH, Lan MY, Chang YY, et al. The thyrocalcitrophic hormones and related minerals in young untreated normoreninergic hypertensive women with noncardiac cerebral ischemia. Acta Neurol Taiwanica 2001;10:21.
22. Rosskopf D, Hartung K, Hense J, et al. Enhanced immunoglobulin formation of immortalized B cells from hypertensive patients. Hypertension 1995;26:432.
23. Khraibi AA. Association between disturbances in the immune system and hypertension. Am J Hypertens 1991;4:635.
24. Suryaprabha P, Padma T, Brahmaji-Rao U. Increased serum IgG levels in essential hypertension. Immunol Lett 1984;8:143.
25. Fannon LD, Braylan RC, Phillips MI. Alterations of lymphocyte populations during development in the spontaneously hypertensive rat. J Hypertens 1992;10:629.
26. Fu ML. Do immune system changes have a role in hypertension? J Hypertens 1995;13:1259.
27. Tomiyama H, Kimura Y, Mitsuhashi H, et al. Relationship between endothelial function and fibrinolysis in early hypertension. Hypertension 1998;31:321.
28. Manfredi AA, Rovere P, Heltai S, et al. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum 1998;41:215.
29. Farsi A, Domeneghetti MP, Fedi S, et al. High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease. Autoimmunity 1999;30:93.
30. Sherer Y, Tenenbaum A, Praprotnik S, et al. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies. Cardiology 2001;95:20.
31. Ruihua Wu, Ulf de Faire, Carola Lemne, et al. Autoantibodies to oxLDL are decreased in individuals with borderline hypertension. Hypertension 1999;33:53.